Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers

PHASE3CompletedINTERVENTIONAL
Enrollment

467

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

October 31, 2015

Conditions
Malaria
Interventions
DRUG

DHA-PPQ

Participants will receive a 3 day course of DHA-PPQ

DRUG

PQ (0.75)

Participants will receive a single dose of PQ at 0.75mg base/kg body weight

DRUG

PQ (0.4)

Participants will receive a single dose of PQ at 0.4mg base/kg body weight

DRUG

PQ (0.2)

Participants will receive a single dose of PQ at 0.2mg base/kg body weight

Trial Locations (1)

Unknown

Medical Research Council Unit (MRC), The Gambia, Fajara

All Listed Sponsors
lead

London School of Hygiene and Tropical Medicine

OTHER

NCT01838902 - Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers | Biotech Hunter | Biotech Hunter